中文

GILEAD SCIENCES, INC. Revenue Breakdown

Period 2026-03-31 (quarterly) ・ Reported 2026-05-07
ItemAmountY/Y
Revenue$6.96B+4.4%
Gross profit$5.51B
Operating income$2.59B
Net income$2.02B+53.7%
Gross margin79.2%Net margin 29.0%

Revenue Segments

SegmentRevenueShare
US$4.93B70.8%
Europe$1.14B16.4%
Rest Of World$0.89B12.8%

Costs & Expenses

ItemAmount% of revenue
Cost of revenue$1.45B20.8%
SG&A$1.45B20.8%
Tax & other$0.56B8.1%
Generate the full Sankey chart →

The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.

Other companies

GPNGLGDDYGSHALHIGHASHCADOCHSICHSYHPE

Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies